The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

NCT03528941 · clinicaltrials.gov ↗

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Lamivudine
OTHER: No prophylaxis

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto